Too late, again?
作者信息
Jones N L
出版信息
Can Respir J. 2001 May-Jun;8(3):127-8. doi: 10.1155/2001/234871.
PMID:11420587
Abstract
摘要
相似文献
1
Too late, again?又太晚了？
Can Respir J. 2001 May-Jun;8(3):127-8. doi: 10.1155/2001/234871.
2
Appetite suppressants and pulmonary hypertension: a long-term risk.食欲抑制剂与肺动脉高压：一项长期风险。
Prescrire Int. 2006 Oct;15(85):183.
3
Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine.
Prog Neuropsychopharmacol Biol Psychiatry. 1998 Oct;22(7):1087-102. doi: 10.1016/s0278-5846(98)00063-3.
4
Anorexigen-related cardiopulmonary toxicity.
Rev Cardiovasc Med. 2000 Fall;1(2):80-9, 102.
5
Scientific and legal issues in fenfluramine/dexfenfluramine litigation.芬氟拉明/右芬氟拉明诉讼中的科学与法律问题。
Tex Med. 2000 Feb;96(2):48-56.
6
Appetite-suppressing drugs and valvular heart disease.食欲抑制药物与心脏瓣膜病
Cardiol Rev. 1999 Nov-Dec;7(6):356-61. doi: 10.1097/00045415-199911000-00014.
7
A big fat settlement. But lawyers for diet-drug users suggest that $3.75 billion is not nearly enough.一笔巨额和解金。但减肥药使用者的律师们认为37.5亿美元远远不够。
US News World Rep. 1999 Oct 18;127(15):74.
8
Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned?肥胖、右芬氟拉明与肺动脉高压。这个教训仍未被吸取？
Am J Respir Crit Care Med. 1997 Mar;155(3):786-8. doi: 10.1164/ajrccm.155.3.9117009.
9
[Appetite depressants and pulmonary hypertension].
Ther Umsch. 1998 Sep;55(9):548-50.
10
[Clinical trials do not guarantee the safety of the medicines. The case of fenfluramine and dexfenfluramine].[临床试验不能保证药物的安全性。芬氟拉明和右芬氟拉明的案例]
Med Clin (Barc). 1999 Nov 6;113(15):598.
Zotero 插件